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'p < 0.05, t P < 0.005
We conclude, MVr causes a more rapid and complete restitution of LVEF,
FS, ESS and contractility (ESS/ESVi) to preop level than MVR, while RVEF
improves rapidly after either.
Echocardiographic Assessment of 148 Young
Surviving Patients with Mitral Valve Repair for
Rheumatic Mitral Regurgitation: Long-term
Observations
Aortic Valve Replacement in Patients with Aortic
Stenosis and Low Transvalvular Gradient
Heidi M. Connolly, Jae K. Oh, Veronique L. Roger, Thomas A. Orszulak, Sara
L. Osborn, David O. Hodge, A. Jamll Tajik. Mavo Clinic, Rochester, MN
It has been suggested that patients (pts) with aortic stenosis (AS), LV dys-
function, and mean gradient (MG) <30 mmHg, do not benefit from aortic
valve replacement (AVR) and hence should not be offered surgery. Since
prognosis without operation is dismal, we reviewed our experience and de-
scribe the outcome of 29 consecutive pts with MG <30 mmHg and EF ;S35%
who underwent AVR between 1985 and 1992; (20 M:9 F, mean age 70 ± 12
yrs). Ninety percent (26/29) of pts were severely symptomatic (NYHA Class
III or IV).
Preoperative hemodynamics demonstrated the following mean values: EF
24 ± 7%, MG 23 ± 4 mmHg, aortic valve area 0.7 ± 0.2 cm2, cardiac output
3.4 ± 1.1 L/min, and peak Doppler aortic velocity 3.3 ± 04 m/sec. Coronary
artery disease (CAD) 1::2 vessel CAD or left main) was present in 16 pts
(55%), 13/29 (45%) had prior MI (2 prior CABG). Coronary bypass at the time
of AVR was performed in 17 pts.
The in-hospital mortality was 24% (7129). One and 5-yearsurvival was 63%
and 40% respectively, at a median follow-up of 1 yr, (up to 7 yrs). The pres-
ence of substantial CAD was similar among pts who survived or died periop-
eratively Mean age of surgical survivors was 68 ± 13 yrs vs 78 ± 5 yrs for pts
who died in the perioperative period (p = 0.059). Clinical follow-up was avail-
able in 19122 survivors, 15 of whom improved ::1 NYHA Class. Eleven pts
were asymptomatic (NYHA Class I) and 5 were Class II at follow-up. Postop
EF in 19 survivors had improved, mean postop EF 35 ± 14%.
Conclusion: (1) Pts with AS, LV systolic dysfunction and MG < 30 mmHg
represent a high risk subset; (2) these pts have an increased operative mor-
tality (24%); (3) however, EF and symptomatic improvement occurs in the
majority of survivors. Based on this experience we conclude that pts with
AS, reduced LVEF and low MG should not be denied AVR.
dation functional class III or IV In 74 patients (1 0.6%)the surgery represented
a reoperation. There were 188 126.9%) isolated aortic valve replacements,
109 (15.6%) iSOlated mitral valve replacements, and 403 (57.6%) combined
procedures which included the replacement of at least one valve. There were
42 (6.0%) double valve replacements in the series. Surgery was performed
as an emergency in 42 patients (6.0%). Hospital mortality was 10.1 % Pl pa-
tients) with 629 hospital survivors. There were 661 valves at risk. Follow-up
extended from one month to 15.4 years with a mean of 48.1 months. The
cumulative follow-up was 2,518.7 patient-years. A total of six valves failed
from structural deterioration, one in the aortic and five in the mitral site lp
< 0.004). Actuarial freedom from valve structural deterioration at six years
was 99.0 ± 0.5% standard error of the mean (SEM; 180 valves at risk) and
93.0 ± 3.5% SEM (eight valves at risk) at 12 years. Gender did not influence
structural deterioration; however, valve site did lp < 0.0041. The results of this
large and long-term experience reinforces the continued use of this device in
elderly patients. The paucity of valve failures and a demonstrated enhanced
quality of life experienced by hospital survivors provides further evidence
for the use of the Carpentier-Edwards bioprosthesis in elderly patients with
acquired valvular heart disease.
John Skoularigis, Vania Sinovich, Pinhas Sareli. Baragwanath Hospital,
Johannesburg, South Africa
Detailed echocardiographic assessment of the structural and functional sta-
tus of mitral (M) valve (V) post MV repair for rheumatic M regurgitation (R)
has not been done previously We followed-up (mean 5 ± 3 years, range
0.1-11) 254 patients with MV repair (72% pure M Rand 28% with associ-
ated mild commissural fusion (MCFI, mean age 18 ± 9 years) and report on
the echo-Doppler findings in 148 survivors without reoperation. Anterior M
leaflet prolapse was present in 37% and retraction in 38%. Severe leaflet
thickening was present in 60% and calcification in 50%. Other findings ac-
cording to initial MV lesion:
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Ventricular Size and Function Early and Late After
Mitral Valve Repair vs Mitral Valve Replacement
for Mitral Regurgitation
The Appropriate Choice of a Cardiac Valve
Prosthesis in Elderly Patients
MV-Replacement In = 11) MV-Repair In = 7)
preop early po late po preop early po late po
LVEFre (%) 50 t 42 NS 44 52 NS 51 NS 53
LVEFex (%) 48 NS 44 NS 48 50 NS 49 NS 55
RVEFre (%) 36 ' 43 NS 45 39 ' 48 NS 50
RVEFex (%) 34' 44 ' 48 30 NS 46 NS 49
LVIDd (cm) 6.2 ' 5.4 NS 5.8 7.3 ' 5.4 NS 5.3
FS(%} 33 t 22 NS 25 34 NS 27 NS 28
ESS 80 t 118 NS 109 86 NS 74 NS 81
ESS/ESVi 2.1 NS 2.1 NS 2.1 1.5 ' 2.0 NS 23
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Detlel Wencker, Jeffrey S. Borer, Clare Hochreiter, Phyllis Supino, Richard
B. Devereux, Mary J. Roman, Paul Kliglield. Cornell Medical Center. New York, NY
Late postop course of left and right ventricular (LV, RV) size and function af-
ter surgical relief of mitral regurgitation (MR) is incompletely defined. More-
over, differences following mitral valve repair (MVr) vs replacement (MVRI
have not been fully assessed. Therefore, in 28 pts who had MVR or MVr we
determined rest (re) and exercise (ex) ejection fraction IRVEF, LVEF), dias-
tolic and systolic LV dimensions (IDd and IDs, n ~ 27), fractional shortening
(FS). LV endsystolic stress (ESS, n ~ 25) and contractility (ESS/ESVi, n = 25)
preop and 4-7 yrs postop Ipo): RVEF (re: 37% to 47%; ex: 33% to 47%) and
ESS/ESVi 12.1 to 2.5) improved and LVIDd (6.4 cm to 5.5 cm) and FS 136%
to 28%) decreased (all p < 0.01) while LVEF (re: 52% to 51 %; ex: 51% to
55%). and ESS (84 kdyn/cm2 to 95 kdyn/cm2) were unchanged (all NS). In a
subset of 18 pts (EFre, n ~ 18, ESS/ESVi, n = 15). additional early «1 yr) po
values were obtained:
To determine the accuracy of TEDSE for detection of CAD in women in rela-
tion to other standard non-invasive tests, we studied 49 women lage 51 ± 10
years, range 33-78) who underwent cardiac catheterization, exercise tread-
mill test (ETI) and stress thallium scintigraphy (TI) for evaluation of chest pain
and suspected CAD. Transesophageal echocardiography was performed us-
ing a biplane (13 patients) or an omniplane probe 136 patients), and dobu-
tamine was infused in stepwise increments up to 40 )lg/kg/min. Ten women
had CAD (::70% stenosis of ::1 major coronary artery) and 39 had normal
coronary angiograms. During TEDSE, chest pain developed in 8 of 10(80%)
women with CAD and in 31 of the 39 (79%) with normal coronary arteries (p
~ NSI. Of the 10 women with CAD, 7 had ST segment depression during ETI,
8 had reversible TI defects, and 8 developed new or worsening wall motion
abnormalities during TEDSE (sensitivity: 70%, 80%, and 80%, respectively;
p = NS). Of the 39 women without CAD, 12 had ST segment depression dur-
ing ETT, 8 had reversible Tl defects, and none developed new or worsening
wall motion abnormalities during TEDSE (specificity: 69%,79%, and 100%,
respectively; p < 0.0021. The overall accuracy was 69% for ETT. 80% for TI.
and 96% for TEDSE (p < 0.003). Thus, TEDSE is an accurate test for detec-
tion of CAD among women presenting with chest pain which, by virtue of its
high specificity, compares favorably with other standard methods.
Dennis F. Pupello, Luis N. Bessone, Stephen P. Hiro, Enrique Lopez-Cuenca,
M.S. Glatlerer, Jr., William W. Angell, John C. Brock, Mark J. Alkire, Edward G. Izzo,
G. Sanabria, George Ebra. St. Joseph's Heart Institute, Tampa, FL
The long-term durability of the Carpentier-Edwards bioprosthesis in elderly
patients exceeds 90% at the end of the first decade. This extensive and
long-term experience provides further impetus for the continued use of this
valve substitute with these patients. From October 1977 to June 1994, 700
patients 70 years of age and over underwent valve replacement using a
Carpentier-Edwards porcine bioprosthesis. Ages ranged from 70 to 93 years
with a mean of 75.9 ± 4.2. There were 398 men 156.9%1 and 302 women
143.1 %). Preoperatively, 98.7% of the patients were in New York Heart Asso-
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MVR was most frequently necessary for increasing MR or symptoms due
to mixed or multiple valve lesions (p < 0.001). Restenosis (loss of half the
initial gain in mitral area) accounted for only 15% of the indications for MVR.
Conclusion: Restenosis is an infrequent indication for MVR after BMV
Other factors including initially insufficient enlargement of the mitral orifice,
persistent symptoms, and progression of post-BMV MR are the major indi-
cations for MVR after balloon mitral valvotomy.
Ted Feldman, John D. Carroll, Howard C. Herrmann, Larry S. Dean, David
R. Holmes, Donald A. Rothbaum, Gerald Dorros, Igor F. Palacios, David
1. Kawanishi, Gregory S. Pavlides, N. American Inoue Investigation. University of
Chicago, Chicago, IL
The indications for mitral valve replacement (MVR) after balloon mitral valvo-
tomy (BMV) remain poorly characterized. Restenosis has been the focus of
most concerns regarding the long-term need for re-BMV or MVR. We re-
viewed the indications for MVR after BMV in 770 patients during 3 years.
MVR was necessary in 4.5% within 30 days of BMV The indication for
MVR was mitral regurgitation (MR) in 3.8% and failed BMV in 0.7%. Late
MVR (more than 30 days post BMV) was done in an additional 6.1 %.
in 62 179.5%) pts and regurgitation was present in 60 (76.9%). stenosis in 5
(6.4%) and both in 13 (16.7%). Five pts had undergone previous surgery for
aortic valve (3 repairs, 2 replacements). Associated mitral surgery was per-
formed in 22 (28.2%) pts. all of them undergoing repairs. The mean bypass
time for isolated Ross procedure was 117.9 ± 36.6 minutes (mins) 174-243
mins) and mean ischemic time 79.8 ± 25.1 mins (46-155 mins). The right
ventricular to pulmonary artery connection was established in all but one
case with homografts. There has been no hospital deaths or documented
thromboembolisms to date. There have been 2 (2.2%) late deaths, 1 unre-
lated and 1 due to systemic sepsis and renal shutdown in a pt with T-cell
abnormality and congenital immune deficiency at 12 and 36 months (mos).
respectively. Four pts (5%) have been reoperated: 1 for mitral valve repair fail-
ure and suture line leak with false aneurysm (6 mas) and 3 for autograft failure
with progressive regurgitation (20-26 mos). One reported valve showed his-
tology compatible with rheumatic valvulitis. Even though the left ventricular
dimensions and function show immediate recovery and are maintained in
the short follow-up, there is a small but definite progression of the autograft
regurgitation followed beyond 6 mos. The effect ofsizing: surgical distortion,
recurrence of rheumatic activity of these transplanted valves and of the re-
paired mitral valves remain to be evaluated in the long-term. In conclusion:
the Ross procedure, while being a safe and excellent option in the young,
growing pts with aortic valve disease, should be moderated by the concerns
expressed above.
Mitral Regurgitation (not Restenosis) is the Most
Frequent Indication for Valve Replacement After
Balloon Mitral Valvotomy
Cardiac Surgery Results in Changes of Atrial
Refractoriness that may Explain Vulnerability to
Postoperative Atrial Fibrillation
Duane P Pool, Harvey L. Leo, George Nadzam, Patrick J. Tchou, Patrick
M. McCarthy, Mina K. Chung. The Cleveland Clinic Foundation, Cleveland, OH
To test the hypothesis that vulnerability to atrial arrhythmias following car-
diac surgery may result from shortening of atrial wavelength (WL), the prod-
uct of conduction velocity ICV) and refractory period, electrophysiologic pa-
rameters were measured in 26 patients undergoing coronary artery bypass
grafting, using temporary atrial epicardial pacing electrodes placed intraop-
eratively. Atrial programmed stimulation was performed before and after car-
diopulmonary bypass (CPB) and daily when possible while electrodes were
intact. After CPB, effective and functional refractory periods (ERR FRP), mea-
sured from 2 atrial sites and at 2 paced cycle lengths (peL), paradoxically
prolonged. After CPB the 8 patients that subsequently developed postoper-
ative atrial fibrillation (AF) had even longer mean ERP (PCL 400, 230 ± 42
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Conclusions: Significant structural and functional V deterioration is com-
mon post MV repair for rheumatic MR. Presence of MCF at initial surgery
is associated with smaller V area and greater V gradient at follow-up as op-
posed to pure MR.
Regression of left ventricular hypertrophy (LVH) after valve replacement has
been studied extensively in the past; however, the time course of regres-
sion of coronary artery size has not yet been evaluated. Thus, cross-sectional
area (CSA) of the proximalleft( = anterior descending + circumflex) and right
coronary artery was determined by biplane quantitative coronary arteriogra-
phy in 10 controls (C) and 23 patients with LVH In = 15 with aortic and 8 with
mitral valve disease) before and 34 ± 28 months after valve replacement.
As an index of the appropriateness of CSA with respect to LV muscle mass
(LMM), CSAwas normalized by 100 g LMM. LMM was 69 ± 14g/m2 in C and
173 + 46 g/m2 in LVH (p < 0.01). Left coronary CSA was markedly increased
in LVH (28 ± 7 vs C = 14 ± 5 mm2; p < 0.01). whereas right coronary CSA
was only slightly (LVH: 12 ± 5 vs C = 8 ± 5 mm2, p < 0.05). Changes in CSA
and LMM early «18 months). intermediate (18--36 months). and late (>36
months after valve replacement were as follows:
Time Course of Regression of Coronary Artery
Size and Left Ventricular Hypertrophy After
Successful Valve Replacement
Giuseppe Vassalli, Bruno Villari, Philipp Kaufmann, Isabella Mayer, Marko Turina,
Otto M. Hess. Cardiology and Cardiovascular Surgery. University Hospital, Zurich,
Switzerland
Normalization of left coronary CSA by 100 g LMM was reduced at early
and indermediate (9 and 10 mm211 00 g, respectively; p < 0.05) but normal
at late follow-up (13 mm2/100 g) when compared to C (12 mm2/100 g). A
positive correlation (r = 0.57, p < 0.01) was found between follow-up and
CSMOO g.
Conclusions: Regression of coronary artery size occurs early after valve re-
placement suggesting a flow-mediated phenomenon. In contrast, LV muscle
mass decreases continuously over several years. Thus, the time course of
regression is different for vessels and muscle which might reflect different
regulatory mechanisms.
Zohair AI-Halees, Naresh Kumar, Begonia Gometza, Ricardo Gallo, Carlos
M.G. Duran. King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Pulmonary autografts have shown promise in the intermediate and long-term
results as being an ideal valve substitute for diseased aortic valve. We have
adopted this procedure as an option for aortic valve replacement, especially
in the young, growing patients who are difficult to anticoagulate. In the pe-
riod between Jan 1990 and Aug 1994, we have performed this procedure on
79 patients (pts), 57 (72%) males and 22 128%) females. Their age ranged
from 1-41 years (yrs) (mean, 18.6 ± 7.36 yrs). The etiology was rheumatic
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